Efficacy of Daratumumab in Refractory Primary Sjögren Disease

Overview

Journal RMD Open

Publisher BMJ Publishing Group

Specialty Rheumatology

Date 2023 Sep 20

PMID 37730313

Authors

Gaetane Nocturne

Oriane Marmontel

Mathilde Di Filippo

Pascale Chretien

Roman Krzysiek

Francois Lifermann

Nawal Rahal

Rakiba Belkhir

Philippe Moulin

Xavier Mariette

Affiliations

Soon will be listed here.

Citing Articles

CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?.

Avouac J, Scherlinger M BioDrugs. 2024; 39(1):5-19.

PMID: 39738985 DOI: 10.1007/s40259-024-00692-z.

Open-Label Phase 1/2 Study of Daratumumab-Based Desensitization Before Kidney Transplantation.

Pilon C, Joher N, Usureau C, Boutin E, Boueilh A, Taupin J Kidney Int Rep. 2024; 9(11):3250-3264.

PMID: 39534185 PMC: 11551132. DOI: 10.1016/j.ekir.2024.08.020.

Autoimmune Diseases and Plasma Cells Dyscrasias: Pathogenetic, Molecular and Prognostic Correlations.

Giordano L, Cacciola R, Barone P, Vecchio V, Nasso M, Alvaro M Diagnostics (Basel). 2024; 14(11).

PMID: 38893662 PMC: 11171610. DOI: 10.3390/diagnostics14111135.

Emerging biologic frontiers for Sjogren's syndrome: Unveiling novel approaches with emphasis on extra glandular pathology.

Li X, Maitiyaer M, Tan Q, Huang W, Liu Y, Liu Z Front Pharmacol. 2024; 15:1377055.

PMID: 38828450 PMC: 11140030. DOI: 10.3389/fphar.2024.1377055.

Safety and Efficacy of Subcutaneous Daratumumab in Systemic AL Amyloidosis.

Hughes M, Lentzsch S Ther Clin Risk Manag. 2024; 19:1063-1074.

PMID: 38164204 PMC: 10758190. DOI: 10.2147/TCRM.S325859.

References

Broeren M, Wang J, Balzaretti G, Groenen P, van Schaik B, Chataway T . Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndrome. Ann Rheum Dis. 2022; 81(5):644-652. PMC: 8995816. DOI: 10.1136/annrheumdis-2021-221604. View

Crickx E, Audia S, Robbins A, Boutboul D, Comont T, Cheminant M . Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia. Haematologica. 2021; 106(12):3198-3201. PMC: 8634173. DOI: 10.3324/haematol.2021.279232. View

Holzer M, Nies J, Oqueka T, Huber T, Kotter I, Krusche M . Successful Rescue Therapy With Daratumumab in Rapidly Progressive Interstitial Lung Disease Caused by MDA5-Positive Dermatomyositis. Chest. 2023; 163(1):e1-e5. DOI: 10.1016/j.chest.2022.08.2209. View

Ostendorf L, Burns M, Durek P, Heinz G, Heinrich F, Garantziotis P . Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus. N Engl J Med. 2020; 383(12):1149-1155. DOI: 10.1056/NEJMoa2023325. View

Beigneux A, Miyashita K, Ploug M, Blom D, Ai M, Linton M . Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia. N Engl J Med. 2017; 376(17):1647-1658. PMC: 5555413. DOI: 10.1056/NEJMoa1611930. View